- Home
- ELDN vs BLDE Comparison
ELDN vs BLDE Comparison
Compare ELDN & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- BLDE
- Stock Information
- Founded
- ELDN 2004
- BLDE 2014
- Country
- ELDN United States
- BLDE United States
- Employees
- ELDN N/A
- BLDE N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- BLDE Aerospace
- Sector
- ELDN Health Care
- BLDE Consumer Discretionary
- Exchange
- ELDN Nasdaq
- BLDE Nasdaq
- Market Cap
- ELDN 288.5M
- BLDE 276.7M
- IPO Year
- ELDN N/A
- BLDE N/A
- Fundamental
- Price
- ELDN $4.29
- BLDE $3.56
- Analyst Decision
- ELDN Strong Buy
- BLDE Buy
- Analyst Count
- ELDN 1
- BLDE 1
- Target Price
- ELDN $16.00
- BLDE $6.00
- AVG Volume (30 Days)
- ELDN 232.7K
- BLDE 560.4K
- Earning Date
- ELDN 03-27-2025
- BLDE 03-11-2025
- Dividend Yield
- ELDN N/A
- BLDE N/A
- EPS Growth
- ELDN N/A
- BLDE N/A
- EPS
- ELDN N/A
- BLDE N/A
- Revenue
- ELDN N/A
- BLDE $241,814,000.00
- Revenue This Year
- ELDN N/A
- BLDE $11.00
- Revenue Next Year
- ELDN N/A
- BLDE $5.14
- P/E Ratio
- ELDN N/A
- BLDE N/A
- Revenue Growth
- ELDN N/A
- BLDE 12.04
- 52 Week Low
- ELDN $1.52
- BLDE $2.45
- 52 Week High
- ELDN $5.54
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- ELDN 44.28
- BLDE 40.62
- Support Level
- ELDN $4.40
- BLDE $3.35
- Resistance Level
- ELDN $4.65
- BLDE $4.05
- Average True Range (ATR)
- ELDN 0.23
- BLDE 0.23
- MACD
- ELDN -0.04
- BLDE -0.00
- Stochastic Oscillator
- ELDN 8.16
- BLDE 29.17
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.